A critical overview of recent investigations into the genetics of schizophrenia

Current Opinion in Psychiatry

Volumn 12, Issue 1, 1999, Pages 29-39

  DeLisi, Lynn E ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CATECHOL METHYLTRANSFERASE; CLOZAPINE; DOPAMINE 2 RECEPTOR; HLA ANTIGEN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTROPHIC FACTOR; NICOTINIC RECEPTOR; POTASSIUM CHANNEL; REPETITIVE DNA; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER;

ATTENTION DEFICIT DISORDER; BRAIN VENTRICLE; CHROMOSOME TRANSLOCATION; DISEASE CLASSIFICATION; EVENT RELATED POTENTIAL; EYE MOVEMENT DISORDER; GENE EXPRESSION; GENETIC COUNSELING; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; MOLECULAR GENETICS; NEUROPHYSIOLOGY; PHARMACOGENETICS; PROMOTER REGION; RECEPTOR GENE; REVIEW; SCHIZOPHRENIA; SEROTONIN METABOLISM; VISUAL STIMULATION;

EID: 0032996549     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199901000-00014     Document Type: Review

References (103)

1. DeLisi LE. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophr Res 1997; 23:119-129. This is an hypothesis about what the genes may be doing and how they connect with the known structural brain findings in schizophrenia.
2. DeLisi LE. The genetics of schizophrenia: past, present and future concepts. Schizophr Res 1997; 28:163-175. This is a review of the state of the field up to early 1997. Because new results are being reported and major international forums have convened since is was written, some of the information may be out of date.
3. Lidz T, Fleck S, Cornelison A. Schizophrenia and the family. New York: International Universities Press; 1965.
4. Wynne LC, Singer MT. Thought disorder and family relations of schizophrenics. Arch Gen Psychiatry 1964; 12:201-212.
5. Kety SS, Rosenthal D, Wender PH, Schulsinger F, Jacobsen B. The biological and adoptive families of adopted individuals who become schizophrenic: prevalence of mental illness and other characteristics. In: The nature of schizophrenia: new approaches to research and treatment. Wynne LC, Cromwell RL, Matthysse S (editors). New York: Wiley; 1978. pp. 25-37.
6. 1997 (Vth) World Congress of Psychiatric Genetics, Santa Fe, New Mexico, October 19-23, 1997. Am J Med Genet: Neuropsychiatr Genet 1997; 74:555-680. This issue contains all abstracts of presentations at this meeting.
7. Horvatta I, Terwilliger JD, Lichtermann D, Makikyro T, Suvisaari J, Peltonen L, Lonnqvist J. Schizophrenia in the genetic isolate of Finland. Am J Med Genet 1997; 74:353-360.
8. Van Os J, Castle DJ, Takei N, Der G, Murray RM. Psychotic illness in ethnic minorities: clarification from the 1991 census. Psychol Med 1996; 26:203-2087.
9. Selten J-P, Slaets JPJ, Kahn RS. Schizophrenia in Surinamese and Dutch Antillean immigrants to the Netherlands: evidence of an increased incidence. Psychol Med 1997; 27:807-811.
10. Erlenmyer-Kimling L, Rock D, Roberts S, Janal M, Cornblatt B, Adamo UH, et al. The New York High-Risk project: comparative effectiveness of selected childhood measures in predicting schizophrenia-related psychosis. Am J Med Genet 1997; 74:594.
11. Erlenmeyer-Kimling L, Adamo UH, Rock D, Roberts SA, Bassett AS, Squires-Wheeler E, et al. The New York high-risk project. Arch Gen Psychiatry 1997; 54:1096-1102.
12. Kendler KS, Karkowski LM, Walsh D. The structure of psychosis: latent class analysis of probands from the Roscommon family study. Arch Gen Psychiatry 1998; 55:492-498.
13. Crow TJ. A continuum of psychosis, one human gene and not much else: the case for homogeneity. Schizophr Res 1995; 17:135-145.
14. Crow TJ. From Kraepelin to Kretschmer leavened by Schneider. Arch Gen Psychiatry 1998; 55:502-504.
15. DeLisi LE, Goldin LR, Maxwell E, Kazuba DM, Gershon ES. Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1987; 44:891-896.
16. Cardno AG, Jones LA, Murphy KC, Sanders RD, Asherson P, Owen MJ, McGuffin P. Dimensions of psychosis in affected sib-pairs [abstract]. Am J Med Genet 1997; 74:561.
17. Loftus JB, DeLisi LE, Crow TJ. Correlation of first rank symptoms in sib-pairs with schizophrenia. Am J Med Genet 1997; 74:562.
18. Kinney DK, Holzman PS, Jacobsen B, Jansson L, Faber B, Hildebrand W, et al. Thought disorder in schizophrenic and control adoptees and their relatives. Arch Gen Psychiatry 1997; 54:475-479.
19. Brzustowicz LM, Honer WG, Chow EWC, Hogan J, Hodgkinson K, Bassett AS. Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. Am J Med Genet 1997; 61:1388-1396. This is a novel approach with a lot of potential. However, the results of this study should be interpreted with caution because the number of subjects and families is small, and the statistical approach needs verifying and confirmation in simulation studies for assurance about the frequency of false positives.
20. Holzman PS, Kringlen E, Levy DL, Proctor LR, Haberman S, Yassilo NJ. Abnormal pursuit eye movements in schizophrenia: evidence for a genetic indicator. Arch Gen Psychiatry 1977; 34:802-805.
21. Litman RE, Torrey EF, Hommer DW, Radant AR, Pickar D, Weinberger DR. A quantitative analysis of smooth pursuit eye tracking in monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry 1997; 54:417-426. This study refutes the notion that smooth pursuit eye movement deficits are genetic markers for schizophrenia.
22. Clementz BA, McDowell JE, Brenner C, Coon H, Byerley W, Myles-Worsley M. Measures of eye movement performance for identifying unaffected gene carriers in schizophrenia pedigrees [abstract]. Am J Med Genet 1997; 74:595.
23. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997; 94:587-592.
24. Green MF, Nuechterlein KH, Breitmeyer B. Backward masking performance in unaffected siblings of schizophrenia patients. Arch Gen Psychiatry 1997; 54:465-472.
25. Reveley AM, Reveley MA, Clifford CA, Murray RM. Cerebral ventricular size in twins discordant for schizophrenia. Lancet 1982; 1:540-541.
26. DeLisi LE, Goldin LR, Hamovit JR, Maxwell E, Kurtz D, Gershon ES. A family study of the association of increased ventricular size with schizophrenia. Arch Gen Psychiatry 1986; 43:148-153.
27. Silverman JM, Smith CJ, Guo SL, Mohs RC, Siever LJ, Davis KL. Lateral ventricular enlargement in schizophrenic probands and their siblings with schizophrenia-related disorders. Biol Psychiatry 1998; 43:97-106.
28. Tsuang MT. Neuropsychological structural, and functional MRI abnormalities in first-degree relatives of schizophrenia patients [abstract]. Am J Med Genet 1997; 74:594.
29. Seidman LJ, Faraone SV, Goldstein JM, Goodman JM, Kremen WS, Matsuda G, et al. Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients: a pilot magnetic resonance imaging study. Am J Med Genet 1997; 74:507-514. This study, using a very small number of individuals, is preliminary and needs to be replicated in a larger sample, with other more advanced gray-white segmentation techniques and with a focus on families with more than one schizophrenic sibling so that the familial aspect to structural abnormalities, as well as whether they segregate with schizophrenia within families, can be determined.
30. DeLisi LE, Sakuma M, Kushner M, Finer DL, Hoff AL, Crow TJ. Anomalous cerebral asymmetry and language processing in schizophrenia. Schizophr Bull 1997; 23:255-271.
31. Reider RO, Gershon ES. Genetic strategies in biological psychiatry. Arch Gen Psychiatry 1978; 35:866-873.
32. DeLisi LE, Crow TJ. Evidence for a sex chromosome locus for schizophrenia. Schizophr Bull 1989; 15:431-440.
33. Dann J, DeLisi LE, Devoto M, Laval S, Nancarrow DJ, Shields G, Smith A. A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. Psychiatry Res 1997; 70:131-143.
34. Laval S, Dann J, Smith A, Shields G, Loftus J, Rue J, DeLisi LE, Crow TJ. A locus for schizophrenia and cerebral asymmetry on the X and Y chromosomes. Neuropsychiatr Genet (in press).
35. Schwartz CE. Invited editorial: X-linked mental retardation: in pursuit of a gene map. Am J Hum Genet 1993; 52:1025-1031.
36. Robertson DMW, Van Amelsvoort TAMJ, Critchley H, Xenitidis K, Daly E, Shapiro MB, Murphy DGM. X chromosome effects on human brain: a study of brain structure and function in adult Turner's syndrome. Am J Med Genet 1997; 74:605.
37. Crow TJ. Is schizophrenia the price that Homo sapiens pays for language? Schizophr Res 1997; 28:127-141.
38. Crow TJ. Genetic predisposition to psychosis as an echo of the speciation event. Am J Med Genet 1997; 74:561.
39. Crow TJ. Was the speciation event on the Y chromosome? Abstracts of Contributions to the Dual Congress of The International Association for the Study of Human Paleontology and The International Association of Human Biologists, June 28-July 4 1998, Sun City, South Africa. p. 109.
40. Sherrington R, Brynjolfsson J, Petursson H, Ptter M, Dudleston K, Barraclough B, et al. Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 1988; 336:164-167.
41. Gill M, Vallada H, Collier D, Sham P, Holmans P, Murray R, et al. A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). Am J Med Genet 1996; 67:40-45.
42. Levinson D, Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6, and 8. Additional support for a schizophrenia linkage to chromosomes 6 and 8. Neuropsychiatr Genet 1996; 67:580-594.
43. DeLisi LE, Kelly M, Shaw S, Cardon L, Joslyn G, Smith AB, et al. Preliminary results of an international genomic scan for schizophrenia [abstract]. Am J Med Genet 1997; 74:558.
44. Shaw SH, Kelly M, Smith AB, Shields G, Hopkins PJ, Loftus J, et al. A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet 1998 (in press).
45. Faraone SV and the NIMH Genetics Initiative-Millennium Schizophrenia Consortium [abstract]. Am J Med Genet 1997; 74:557.
46. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B. Genome scan of European-American schizophrenia pedigrees: results of the NIMH genetics initiative and millennium consortium. Am J Med Genet 1998; 81:290-295.
47. Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Markel PD, Meyer J. NIMH Genetics initiative millennium schizophrenia consortium: linkage analysis of African-American pedigrees. Am J Med Genet 1998; 81:282-289. A very small number of families were used in these analyses. The cohort was split from the Faraone et al. [49] cohort based on their Afro-American heritage. There is no genetic evidence to date to do this.
48. Levinson DF, Mahtani MM, Nancarrow DJ, Brown DM, Kruglyak L, Kirby A, et al. Genome scan of schizophrenia. Am J Psychiatry 1998; 155:741-750.
49. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, et al. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nature Genet 1995; 11:321-324.
50. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G, et al. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: part I. Am J Med Genet 1994; 54:36-43.
51. Pulver AE, Lassetter VK, Kasch L, Wolyniec P, Nestadt G, Blouin JL, et al. Schizophrenia: a genome scan targets chromosome 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 1995; 60:252-260.
52. Blouin J-L, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nature Genet 1998; 20:70-73.
53. Straub RE, MacLean CJ, Martin RB, Ma Y, Myakishev MV, Harris-Kerr C, et al. A schizophrenia locus may be located in region 10p15-p11. Am J Med Genet 1998; 81:296-301.
54. Straub RE, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, et al. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nature Genet 1996; 11:287-293.
55. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS. Support for a possible schizophrenia vulnerability locus in a region of 5q22-31 in Irish families. Mol Psychiatry 1997; 2:148-155.
56. Schwab SG, Hallmeyer J, Albus M, Lerer B, Hanses C, Kanyas K, et al. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet 1998; 81:302-307.
57. Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Borrmann M, et al. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry 1997; 2:156-160.
58. Wildenauer DB, Albus M, Schwab SG, Hallmeyer J, Hanses C, Eckstein GN, et al. Searching for susceptibility genes in schizophrenia by affected sibpair analysis (Germany) [abstract]. Am J Med Genet 1997; 74:558.
59. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A, et al. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 1997; 43:1-8.
60. Henn FA, DeLisi LE (editors). Neurochemistry and neuropharmacology of schizophrenia. Handbook of schizophrenia. Amsterdam: Elsevier; 1987.
61. Gejman PV, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D, et al. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. JAMA 1994; 271:204-208.
62. Goldman D, Urbanek M, Guenther D, Robin R, Long JC. Linkage and association of a functional DRD2 variant [Ser311Cys] and DRD2 markers to alcoholism, substance abuse and schizophrenia in Southwestern American indians. Am J Med Genet 1997; 74:386-394.
63. Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K, et al. European multicentre association study of schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am J Med Genet 1998; 81:24-28.
64. Stober G, Jatzke S, Heils A, Jungkunz G, Knapp M, Mossner R, et al. Insertion/deletion variant ( - 141C ins/del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. J Neural Transmission 1998; 105:101-109.
65. Hawi Z, McCabe U, Straub RE, O'Neill A, Kendler KS, Walsh D, Gill M. Examination of new and reported data of the DRD3/Mscl polymorphism: no support for the proposed association with schizophrenia. Mol Psychiatry 1998; 3:150-155.
66. Williams J, Spurlock G, Holmans P, Mant R, Murphy K, Jones L, et al. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry 1998; 3:141-149.
67. Hong C-J, Lee Y-L, Sim C-B, Hwu H-G. Dopamine D4 receptor variants in Chinese sporadic and familial schizophrenics. Am J Med Genet 1997; 74:412-415.
68. Asherson P, Mant R, Williams N, Cardno A, Jones L, Murphy K, et al. A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder. Mol Psychiatry 1998; 3:310-320.
69. Tamminga CA. Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 1998; 12:21-36.
70. Mendes de Oliveira JR, Otto PA, Vallada H, Lauriano V, Elkis H, Lafer B, et al. Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia. Am J Med Genet 1998; 81:225-227.
71. Bonnet-Brilhault F, Laurent C, Thibaut F, Campion D, Chavand O, Samolyk D, et al. Biol Psychiatry 1997; 42:634-636.
72. Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D. A functional serotonin transporter polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Am J Med Genet 1997; 74:613.
73. Arranz MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, et al. Evidence for association between polymorphisms in the promoter and coding regions of the 5HT2A receptor gene and response to clozapine [abstract]. Am J Med Genet 1997; 74:615.
74. Williams J, McGuffin P, Nothen M, Owen MJ. A meta analysis of association between the 5HT2a receptor T102C polymorphism and schizophrenia. Lancet 1997; 349:1221.
75. Tay AHN, Lim LCC, Lee WL, Wong KE, Wong LY, Tsoi WF. Association between allele 1 of T102C polymorphism, 5-Hydroxytryoptamine 2a receptor gene and schizophrenia in Chinese males in Singapore. Hum Hered 1997; 47:298-300.
76. Hawi Z, Myakishev MV, Straub RE, O'Neill A, Kendler KS, Walsh D, Gill M. No association or linkage between the 5-HT2a/T102C polymorphism and schizophrenia in Irish families. Am J Med Genet 1997; 74:370-373.
77. Kouzmenko AP, Hayes WL, Pereira AM, Dean B, Burnet PWJ, Harrison PJ. 5-HT2a receptor polymorphism and steady state receptor expression in schizophrenia. Lancet 1997; 349:1815.
78. Spurlock G, Heils A, Holmans P, Williams J, D'Souza UM, Cardno A, et al. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol Psychiatry 1998; 3:42-49.
79. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J. Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 1998; 155:835-837.
80. Karayiorgou M, Gogos JA, Galke BL, Wolyniec PS, Nestadt G, Antonarakis SE, et al. Identification of sequence variants and analysis of the role of catechol-O-methyl-transferase gene in schizophrenia susceptibility. Biol Psychiatry 1998; 43:417-424. This is a definitive study that clearly shows no role for catechol-O-methyltransferase in the genetics of schizophrenia.
81. Gault J, Jacobs S, Logel J, Drebing C, Barnhart M, Leonard S. Southern analysis of the alpha 7 nicotinic acetylcholine receptor in schizophrenics. Am J Med Genet 1997; 74:614-615.
82. Thome J, Foley P, Riederer P. Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. J Neural Transmission 1998; 105:85-100. This is a good review of relevant neurotrophic factors and how they may be related to the development of schizophrenia. However, it fails to examine where any of these are mapped in the genome and whether they relate to any of the linkages reported.
83. Vicente AM, Macciardi F, Verga M, Bassett AS, Honer WG, Bean G, Kennedy JL. NCAM and schizophrenia: genetic studies. Mol Psychiatry 1997; 2:65-69.
84. Sakai T, Sasaki T, Tatsumi M, Kunugi H, Hattori M, Nanko S. Schizophrenia and the ciliary neurotrophic factor (CNTF) gene: no evidence for association. Psychiatry Res 1997; 71:7-10.
85. Jonsson E, Brene S, Zhang XR, Nimgaonkar VL, Tylec A, Schalling M, Sedvall G. Schizophrenia and neurotrophin-3 alleles. Acta Psychiatr Scand 1997; 95:414-419.
86. Thome J, Durany N, Palomo A, Foley P, Harsanyi A, Baumer A, et al. Variants in neurotrophic factor genes and schizophrenic psychoses: no associations in a Spanish population. Psychiatry Res 1997; 71:1-5.
87. Crow TJ, Ball J, Bloom SR, Brown R, Bruton CJ, Colter N, Frith CD. Schizophrenia as an anomaly of development of cerebral asymmetry: a postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry 1989; 46:1145-1150.
88. Goldin LR, DeLisi LE, Gershon ES. Relationship of HLA to schizophrenia in 10 nuclear families. Psychiatry Res 1987; 20:69-77.
89. Lahdelma L, Ahokas A, Andersson LC, Huttunen M, Sama S, Koskimies S. Association between HLA-A1 allele and schizophrenia gene(s) in patients refractory to conventional neuroleptics but responsive to clozapine medication. Tissue Antigens 1998; 51:200-203.
90. Powchik P, Friedman J, Haroutunian H, Greenberg D, Altsteil L, Purohit D, et al. Apolipoprotein E4 in schizophrenia: a study of one hundred sixteen cases with concomitant neuropathological examination. Biol Psychiatry 1997; 42:296-298.
91. Arnold SE, Joo E, Martinoli M-G, Roy N, Trojanowski JQ, Gur RE, et al. Apolipoprotein E genotype in schizophrenia: frequency, age of onset, and neuropathologic features. NeuroReport 1997; 8:1523-1526.
92. Town T, Fallin D, Crawford F, Walsh S, Solomon R, Mullan M. Lack of association between the apolipoprotein E e4 allele (APOE e4) and chronic schizophrenia. Am J Med Genet 1997; 74:451-452.
93. Sorbi S, Nacmias B, Tedde A, Latorraca S, Forleo P, Guarnieri BM, et al. No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. Neurosci Lett 1998; 244:118-120.
94. Chandy KG, Fantino E, Wittekindt O, Kalman K, Tong Li-Li, Ho T-H, et al. Mol Psychiatry 1998; 3:32-37.
95. Bowen T, Guy CA, Craddock N, Cardno AG, Williams NM, Spurlock G, Murphy KC. Further support for an association between polymorphic CAG repeat in the hKCa3 gene and schizophrenia. Mol Psychiatry 1998; 3:266-269.
96. Smith AB, Peterson P, Weiland J, Moriarty T, DeLisi LE. Chromosome 18 translocation (18;21) (p11.1;p11.1) associated with psychosis in one family. Am J Med Genet 1996; 67:560-563.
97. Arveiler B, Boisseau P, Petit J, Taine L. Gene mapping in region 1q42.1 around a translocation breakpoint associated with schizophrenia [abstract]. Neuropsychiatr Genet 1997; 74:560.
98. Gothelf D, Frisch A, Munitz H, Rockah R, Aviram A, Mozes T, et al. Velocardiofacial manifestations and microdeletions in schizophrenic inpatients. Am J Med Genet 1997; 72:455-461.
99. Sirugo G, Pakstis AJ, Kidd KK, Matthysse S, Levy DL, Holzman PS, et al. Am J Med Genet 1997; 74:546-548.
100. Burgess CE, Lindblad K, Sidransky E, Yuan Q-P, Long RT, Breschel T, et al. Large CAG/CTG repeats are associated with childhood schizophrenia. Mol Psychiatry 1998; 3:321-327. According to the expanded repeat hypothesis, age of onset will be successively earlier from generation to generation. Thus, a study of children who already have developed schizophrenia would be an excellent focus for finding expanded repeats, it any patients with this diagnosis have them. This study, although small (n=36), found a significantly greater percentage of CAG/CTG repeats greater than 180 nucleotides in the patients (42%) compared with control individuals (29.5%). This difference was significant for male, but not female patients. The authors note, however, that there was an unusually low number of repeats in the control males and show preliminary data that this may be due to variable ethnic origin of groups.
101. Schalling M, Hudson TJ, Buetow KH, Housman DE. Direct evidence of novel expanded trinucleotide repeats in the human genome. Nature Genet 1993; 4:135-139.
102. Jones AL, Middle F, Guy C, Spurlock G, Cairns NJ, McGuffin P, et al. No evidence for expanded polyglutamine sequences in bipolar disorder and schizophrenia. Mol Psychiatry 1997; 2:478-482.
103. Gottesman II, Shields J. Schizophrenia: the epigenetic puzzle. Cambridge University Press: New York, 1982.